secwatch.observer — SEC 8-K summary
======================================

Issuer:     HOLOGIC INC (—)
CIK:        0000859737
Form:       8-K
Filed at:   2026-04-07T23:59:59+00:00
Accession:  0001193125-26-144632
Event type: m_and_a
Sentiment:  neutral
Materiality: 1.00
Item codes: 1.01, 2.01, 1.02, 3.01, 3.03, 5.01, 5.02, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Hologic acquired by Blackstone & TPG for $76/share; CEO Almeida appointed
-------------------------------------------------------------------------

- Total consideration up to $79/share ($76 cash plus up to $3 CVR); enterprise value ~$17.3B.
- Hologic becomes private; stock delisted from Nasdaq; holders receive cash and non-tradable CVR tied to Breast Health goals.
- CEO Stephen MacMillan retired; José (Joe) Almeida named CEO effective immediately; Almeida was CEO of Baxter and Covidien.
- Minority investments from ADIA and GIC; redeemed $400M 4.625% 2028 notes and $950M 3.25% 2029 notes at closing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/859737/000119312526144632/0001193125-26-144632-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/859737/000119312526144632/d135035d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-144632

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer